人工器官市场：按器官类型、患者类型、最终用户、应用、技术和地区划分

2025年人造器官市场规模估计为215.1亿美元，预计到2032年将达到383.2亿美元，2025年至2032年的年复合成长率（CAGR）为8.6%。

全球人工器官市场代表着医疗技术的革命性前沿，它不仅解决了全球严重的捐赠器官短缺问题，也为数百万个器官衰竭患者带来了希望。人工器官是用于替代或支持衰竭生物器官功能的人工医疗设备，涵盖多种技术，包括机械装置、生物工程组织和混合系统。

市场涵盖各种类型的器官，包括人工心臟、人工肾臟、人工肺、人工肝臟、人工胰臟和人工肢体，每种器官都采用先进的材料科学、生物相容性工程和精良的製造技术。慢性疾病的增加、人口老化以及生活方式相关的器官衰竭，正在推动对人工器官解决方案的需求。这些挽救生命的技术涵盖了从支持等待移植患者的临时桥接装置，到恢復正常生理功能的永久性器官替代品。

这个市场包括可植入设备和外部支援系统，利用生物材料、3D 列印、组织工程和再生医学领域的尖端创新。随着世界各地的医疗保健系统面临器官捐赠短缺和漫长的等待名单，人造器官已成为一种有前途的替代方案，可提供即时可用性、可自订的规格，并消除与传统器官移植相关的免疫排斥风险。

市场动态

全球人工器官市场受到多种强劲市场驱动因素的推动，凸显了其在现代医疗保健中的重要性。主要驱动因素是全球捐赠器官的严重短缺，目前有超过10万美国人在器官等待名单上，全球范围内也有类似的统计数据，这导致对人工替代器官的需求迫切。糖尿病、心血管疾病、肾衰竭和肝硬化等慢性疾病的盛行率不断上升，加上人口老化，显着增加了对器官替代解决方案的需求。

生物材料、3D 生物列印、组织工程和奈米技术的进步正在彻底改变人造器官的发展，使设备更加生物相容性、耐用性和功能性。政府支持研发的措施、不断上涨的医疗成本以及人们对人造器官益处的日益认识，进一步加速了市场的发展。然而，市场面临重大製约，包括非常高的市场开发和製造成本，使人造器官昂贵，许多患者可能无法获得。严格的监管核准流程需要大量的临床试验和安全检验，这给製造商带来了漫长的审批时间和巨大的财务障碍。与生物相容性、设备寿命、感染风险和实现自然器官功能相关的技术挑战仍然是重大障碍。保险公司的报销有限以及对人造器官部署的伦理担忧也限制了市场扩张。

儘管面临诸多挑战，但随着医疗基础设施的改善、医疗旅游业的蓬勃发展以及可支配收入的不断提高，新兴市场蕴藏着巨大的机会。学术机构、生技公司和医疗设备製造商之间的合作正在促进创新，加速产品开发。人工智慧、机器学习和物联网技术在人工器官设计中的融合，为能够即时监测和调整功能的智慧自适应设备带来了革命性机会，有望彻底改变患者治疗效果和市场动态。

本次调查的主要特点

• 本报告对全球人工器官市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
• 它还揭示了各个领域的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
• 它根据公司亮点、产品系列、关键亮点、财务业绩和策略等参数，对全球人工器官市场的主要企业进行了概述。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球人工器官市场报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
• 透过分析全球人工器官市场所使用的各种策略矩阵，相关人员将更容易做出决策。

目录

第一章：调查目标和先决条件

• 调查目的
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章：市场动态、法规与趋势分析

• 市场动态
• 驱动程式
• 抑制因素
• 机会
• 影响分析
• 主要进展
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景
• 产业趋势

4. 2020-2032 年全球人工器官市场（依器官类型）

• 人工心臟
• 人工肾
• 人工肝
• 人工胰臟
• 人工肺
• 感觉器官
• 角膜植入
• 其他（神经控制义肢）

5. 2020-2032 年全球人工器官市场（依病患类型）

• 新生
• 孩子们
• 成人

6. 2020-2032 年全球人工器官市场（依最终用户划分）

• 医院
• 移植中心
• 门诊手术中心
• 急救和创伤中心
• 居家照护环境
• 其他（研究机构等）

7. 2020-2032 年全球人工器官市场应用状况

• 移植
• 慢性病管理
• 其他紧急或急性治疗

8. 2020-2032 年全球人工器官市场（依技术划分）

• 机械的
• 电子或仿生
• 生物力学混合体
• 基于生物材料的技术（例如去细胞支架、3D生物列印组织）
• 其他的

9. 2020-2032 年全球人工器官市场（按地区）

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第十章 竞争格局

• Abbott Laboratories
• Medtronic plc
• Boston Scientific Corporation
• Asahi Kasei Corporation
• Fresenius Medical Care AG
• Baxter International Inc.
• SynCardia Systems LLC
• Jarvik Heart Inc.
• Cochlear Limited
• Ottobock SE & Co. KGaA
• Second Sight Medical Products
• Ekso Bionics Holdings Inc.
• Abiomed Inc.
• Organovo Holdings Inc.
• Carmat SA

第 11 章分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十二章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Artificial Organ Market is estimated to be valued at USD 21.51 Bn in 2025 and is expected to reach USD 38.32 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2032.

The global artificial organ market represents a revolutionary frontier in medical technology, addressing the critical shortage of donor organs worldwide while offering hope to millions of patients suffering from organ failure. Artificial organs, engineered medical devices designed to replace or support the function of failing biological organs, encompass a diverse range of technologies including mechanical devices, bioengineered tissues, and hybrid systems.

This market spans various organ types such as artificial hearts, kidneys, lungs, liver, pancreas, and limbs, each utilizing sophisticated materials science, biocompatibility engineering, and advanced manufacturing techniques. The increasing prevalence of chronic diseases, aging populations, and lifestyle-related organ failures has intensified the demand for artificial organ solutions. These life-saving technologies range from temporary bridging devices that sustain patients awaiting transplants to permanent organ replacements that restore normal physiological function.

The market encompasses both implantable devices and external support systems, leveraging cutting-edge innovations in biomaterials, 3D printing, tissue engineering, and regenerative medicine. As healthcare systems worldwide grapple with organ donor shortages and extended waiting lists, artificial organs emerge as a promising alternative, offering immediate availability, customizable specifications, and elimination of immunological rejection risks associated with traditional organ transplantation.

Market Dynamics

The global artificial organ market is propelled by several compelling drivers that underscore its critical importance in modern healthcare. The primary driver stems from the severe shortage of donor organs worldwide, with over 100,000 Americans currently on organ waiting lists and similar statistics globally, creating an urgent need for artificial alternatives. Rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, kidney failure, and liver cirrhosis, coupled with aging populations, significantly amplifies demand for organ replacement solutions.

Technological advancements in biomaterials, 3D bioprinting, tissue engineering, and nanotechnology are revolutionizing artificial organ development, making devices more biocompatible, durable, and functionally superior. Government initiatives supporting research and development, increased healthcare expenditure, and growing awareness about artificial organ benefits further accelerate market growth. However, the market faces substantial restraints including extremely high development and manufacturing costs, making artificial organs expensive and potentially inaccessible to many patients. Stringent regulatory approval processes requiring extensive clinical trials and safety validations create lengthy timelines and significant financial barriers for manufacturers. Technical challenges related to biocompatibility, device longevity, infection risks, and achieving natural organ functionality remain significant hurdles. Limited reimbursement coverage by insurance providers and ethical concerns regarding artificial organ implementation also constrain market expansion.

Despite these challenges, immense opportunities exist through emerging markets with improving healthcare infrastructure, increasing medical tourism, and rising disposable incomes. Collaborative research between academic institutions, biotechnology companies, and medical device manufacturers is fostering innovation and accelerating product development. The integration of artificial intelligence, machine learning, and IoT technologies in artificial organ design presents revolutionary opportunities for smart, adaptive devices that can monitor and adjust their functionality in real-time, potentially transforming patient outcomes and market dynamics.

Key features of the study

• This report provides an in-depth analysis of the global artificial organ market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global artificial organ market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include leading Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Asahi Kasei Corporation, Fresenius Medical Care AG, Baxter International Inc., SynCardia Systems LLC, Jarvik Heart Inc., Cochlear Limited, Ottobock SE & Co. KGaA, Second Sight Medical Products, Ekso Bionics Holdings Inc., Abiomed Inc., Organovo Holdings Inc., and Carmat SA.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global artificial organ market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial organ market.

Market Segmentation

• Organ Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Artificial Heart
  • Ventricular Assist Devices (VADs)
  • Total Artificial Hearts (TAHs)
  • Artificial Kidney
  • Wearable Artificial Kidneys
  • Implantable Renal Devices
  • Artificial Liver
  • Bioartificial Liver Support Systems
  • Extracorporeal Liver Assist Devices
  • Artificial Pancreas
  • Closed-Loop Insulin Delivery Systems
  • Implantable Glucose Monitors
  • Artificial Lungs
  • Extracorporeal Membrane Oxygenation (ECMO)
  • Implantable Oxygenators
  • Sensory Organs
  • Cochlear Implants (Hearing)
  • Retinal Implants (Vision)
  • Corneal Implants
  • Bionic Limbs
  • Myoelectric Prosthetics
  • Others (Neuro-Controlled Prostheses)
• Patient Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Neonates
  • Pediatric
  • Adult
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Transplant Centers
  • Ambulatory Surgical Centers
  • Emergency and Trauma Centers
  • Home Care Settings
  • Others (Research Institutes, etc.)
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Transplantation
  • Chronic Disease Management
  • Other Emergency or Acute Care
• Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • Mechanical
  • Electronic or Bionic
  • Biomechanical Hybrid
  • Biomaterials-Based Technology (e.g., Decellularized Scaffolds, 3D-Bioprinted Tissues)
  • Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Abbott Laboratories
  • Medtronic plc
  • Boston Scientific Corporation
  • Asahi Kasei Corporation
  • Fresenius Medical Care AG
  • Baxter International Inc.
  • SynCardia Systems LLC
  • Jarvik Heart Inc.
  • Cochlear Limited
  • Ottobock SE & Co. KGaA
  • Second Sight Medical Products
  • Ekso Bionics Holdings Inc.
  • Abiomed Inc.
  • Organovo Holdings Inc.
  • Carmat SA

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Artificial Organ Market, By Organ Type
  • Global Artificial Organ Market, By Patient Type
  • Global Artificial Organ Market, By End User
  • Global Artificial Organ Market, By Application
  • Global Artificial Organ Market, By Technology
  • Global Artificial Organ Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Artificial Organ Market, By Organ Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Artificial Heart
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Ventricular Assist Devices (VADs)
    • Total Artificial Hearts (TAHs)
• Artificial Kidney
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Wearable Artificial Kidneys
    • Implantable Renal Devices
• Artificial Liver
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Bioartificial Liver Support Systems
    • Extracorporeal Liver Assist Devices
• Artificial Pancreas
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Closed-Loop Insulin Delivery Systems
    • Implantable Glucose Monitors
• Artificial Lungs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Extracorporeal Membrane Oxygenation (ECMO)
    • Implantable Oxygenators
• Sensory Organs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Cochlear Implants (Hearing)
    • Retinal Implants (Vision)
• Corneal Implants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Bionic Limbs
    • Myoelectric Prosthetics
• Others (Neuro-Controlled Prostheses)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Artificial Organ Market, By Patient Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Neonates
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Artificial Organ Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Transplant Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Emergency and Trauma Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Research Institutes, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Artificial Organ Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Transplantation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chronic Disease Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Other Emergency or Acute Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Artificial Organ Market, By Technology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Mechanical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Electronic or Bionic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Biomechanical Hybrid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Biomaterials-Based Technology (e.g., Decellularized Scaffolds, 3D-Bioprinted Tissues)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Artificial Organ Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Organ Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Asahi Kasei Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fresenius Medical Care AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Baxter International Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SynCardia Systems LLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Jarvik Heart Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cochlear Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ottobock SE & Co. KGaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Second Sight Medical Products
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ekso Bionics Holdings Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abiomed Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Organovo Holdings Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Carmat SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us